Zhao Chunjiang, Yang Shuo, Zhang Feifei, Wang Zhanwei, Zhang Yawei, Wang Xiaojuan, Li Henan, Chen Hongbin, Wang Hui
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Infect Drug Resist. 2022 Aug 31;15:5069-5083. doi: 10.2147/IDR.S374805. eCollection 2022.
Emergence of antimicrobial resistance poses new challenges in the management of community acquired respiratory tract infections (CARTIs). Therefore, surveillance on the antimicrobial susceptibilities of common respiratory pathogens is valuable and guides empirical therapeutic choices in management of CARTIs.
The objective of the current study is to summarize the antimicrobial resistance trends in common respiratory tract pathogens isolated from patients with CARTIs in China, over a 10-year period (2009-2018).
strains were collected from multicenter, and antimicrobial susceptibility testing was performed in the research central laboratory of each study period from 2009-2018. The pathogens that accounted for CARTIs in the adult population was considered and summarized.
From 2009-2018 a total of 3750 isolates were collected from 22 cities located across different regions of China. Among these the most common bacterial isolates include (53.7%) followed by (32.4%), (13.9%). exhibited reduction in susceptibility and increase in resistance to penicillin, cephalosporins (cefaclor, cefuroxime, ceftriaxone) during the surveillance period. Invasive and noninvasive showed similar resistance. In the case of susceptibility to β-lactam and β-lactamase inhibitors (ampicillin, amoxicillin and AMC), SXT, clarithromycin and cephalosporins (cefuroxime, cefaclor, ceftazidime) was reduced over the past 10 years with an exception of ceftriaxone. Overall, moxifloxacin and levofloxacin have the highest susceptibility rates against (>95%) and (>90%). exhibited susceptibility to almost all the tested antimicrobials.
In China the 10-year trends showed a substantial increase in resistance to β-lactam drugs and reduction in sensitivity. However, certain antimicrobial agents namely fluoroquinolones including moxifloxacin and levofloxacin maintained low resistance rates with better susceptibility. Further, with few exceptions decline in susceptibility rates to macrolides and cephalosporins was observed among the tested pathogens.
抗菌药物耐药性的出现给社区获得性呼吸道感染(CARTIs)的管理带来了新的挑战。因此,监测常见呼吸道病原体的抗菌药物敏感性对于指导CARTIs管理中的经验性治疗选择具有重要价值。
本研究的目的是总结中国10年间(2009 - 2018年)从CARTIs患者中分离出的常见呼吸道病原体的抗菌药物耐药性趋势。
从多中心收集菌株,并在2009 - 2018年各研究阶段的研究中心实验室进行抗菌药物敏感性测试。对成年人群中导致CARTIs的病原体进行了分析和总结。
2009 - 2018年期间,共从中国不同地区的22个城市收集了3750株分离株。其中最常见的细菌分离株包括(53.7%),其次是(32.4%),(13.9%)。在监测期间,对青霉素、头孢菌素(头孢克洛、头孢呋辛、头孢曲松)的敏感性降低,耐药性增加。侵袭性和非侵袭性表现出相似的耐药性。在对β-内酰胺类和β-内酰胺酶抑制剂(氨苄西林、阿莫西林和AMC)、SXT、克拉霉素和头孢菌素(头孢呋辛、头孢克洛、头孢他啶)的敏感性方面,除头孢曲松外,过去10年有所降低。总体而言,莫西沙星和左氧氟沙星对(>95%)和(>90%)的敏感性最高。对几乎所有测试抗菌药物均表现出敏感性。
在中国,10年趋势显示对β-内酰胺类药物的耐药性大幅增加,敏感性降低。然而,某些抗菌药物,即包括莫西沙星和左氧氟沙星在内的氟喹诺酮类药物,耐药率较低,敏感性较好。此外,在所测试的病原体中,除少数例外,对大环内酯类和头孢菌素类药物的敏感性率有所下降。